Multiparametric liver MRI could refine the way we currently approach testing of therapeutic candidates in preclinical models
Research led by Professor Jonathan Fallowfield, Chair of Translational Liver Research at University of Edinburgh, in collaboration with GlaxoSmithKline, showed…
3 Jul 2018
Analysis of Biobank data shows 1 in 8 adults may have NASH
UK Biobank is a major national and international health resource, and a registered charity in its own right. UK Biobank's aim is to improve the prevention, dia…
15 Apr 2018
LiverMultiScan™ analysis of UK Biobank indicates as many as 1 in 8 adults may have non-alcoholic steatohepatitis (NASH)
Perspectum Diagnostics today revealed new data which indicates that the prevalence of non-alcoholic steatohepatitis (NASH) among UK adults could be as high as …
13 Apr 2018
LiverMultiScan™ Receives FDA 510(k) Clearance for Version 2 of Medical Device
We are delighted to announce that LiverMultiScan™ has received FDA 510(k) clearance for the next release of the software. Read the full press release below: …
27 Nov 2017
LITMUS Project – LiverMultiScan™ included in ground-breaking €34 million project to develop better test for liver disease
A pioneering European research project aims to lead to new diagnostic tests to assess patients with non-alcoholic fatty liver disease (NAFLD) and identify thos…
24 Nov 2017